An Efficacy and Safety Study of Fremanezumab in Adults With Migraine
Clinical trial NCT03308968 · COMPLETED
Trial details
- NCT number
- NCT03308968
- Sponsor
- Teva Branded Pharmaceutical Products R&D, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-10-13
- Primary completion
- 2018-10-02
- Enrollment
- 838
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.